Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Duval

Showing results (91-100 of 283) with videos related to

Pageof 29
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2007
Is phosphatemia the best tool to monitor renal tenofovir toxicity?Marie Essig, Xavier Duval, Firas Al Kaied, et al.
Therapeutic Drug Monitoring|April 10, 2007
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adultsFidéline Collin, Geneviève Chêne, Sylvie Retout, et al.
AIDS (London, England)|March 21, 2009
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adultsFidéline Collin, Xavier Duval, Vincent Le Moing, et al.
European Journal of Clinical Pharmacology|May 15, 2009
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTJulie Bertrand, Jean-Marc Treluyer, Xavière Panhard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 6, 2014
Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditisAlfred Mahr, Frédéric Batteux, Sarah Tubiana, et al.
Trials|May 31, 2021
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemicAmandine Gagneux-Brunon, Clémentine Schilte, Arnauld Garcin, et al.
The Canadian Journal of Cardiology|December 3, 2014
First reported human case of native mitral infective endocarditis caused by Streptococcus canisMyriam Amsallem, Bernard Iung, Claire Bouleti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 9, 2026
Which trial do we need? Evaluating plasma microbial cell-free DNA in blood culture-negative infective endocarditisDavid Mokrani, Laurène Deconinck, Nathan Peiffer-Smadja, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBlaise K Kutala, Jeremie Guedj, Tarik Asselah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapyGuillaume Breton, Xavier Duval, Candice Estellat, et al.
Pageof 29

Showing results (91-100 of 283) with videos related to

Sort By:
Pageof 29
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2007
Is phosphatemia the best tool to monitor renal tenofovir toxicity?Marie Essig, Xavier Duval, Firas Al Kaied, et al.
Therapeutic Drug Monitoring|April 10, 2007
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adultsFidéline Collin, Geneviève Chêne, Sylvie Retout, et al.
AIDS (London, England)|March 21, 2009
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adultsFidéline Collin, Xavier Duval, Vincent Le Moing, et al.
European Journal of Clinical Pharmacology|May 15, 2009
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTJulie Bertrand, Jean-Marc Treluyer, Xavière Panhard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 6, 2014
Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditisAlfred Mahr, Frédéric Batteux, Sarah Tubiana, et al.
Trials|May 31, 2021
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemicAmandine Gagneux-Brunon, Clémentine Schilte, Arnauld Garcin, et al.
The Canadian Journal of Cardiology|December 3, 2014
First reported human case of native mitral infective endocarditis caused by Streptococcus canisMyriam Amsallem, Bernard Iung, Claire Bouleti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 9, 2026
Which trial do we need? Evaluating plasma microbial cell-free DNA in blood culture-negative infective endocarditisDavid Mokrani, Laurène Deconinck, Nathan Peiffer-Smadja, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBlaise K Kutala, Jeremie Guedj, Tarik Asselah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapyGuillaume Breton, Xavier Duval, Candice Estellat, et al.
Pageof 29